{
    "Title": "Identification and Characterization of Hundreds of Potent and Selective Inhibitors of Trypanosoma brucei Growth from a Kinase-Targeted Library Screening Campaign",
    "URL": "https://doi.org/10.1371/journal.pntd.0003253",
    "Published": "October 23, 2014",
    "Subject_Areas": [
        "Trypanosoma brucei gambiense",
        "Parasitemia",
        "Parasitic diseases",
        "Kinase inhibitors",
        "Blood",
        "Central nervous system",
        "Pharmacokinetics",
        "Curve fitting"
    ],
    "Authors": {
        "Rosario Diaz": [
            "Instituto de Parasitolog\u00eda y Biomedicina "
        ],
        "Sandra A. Luengo-Arratta": [
            "Instituto de Parasitolog\u00eda y Biomedicina ",
            "Department of Chemistry and Chemical Biology and Center for Drug Discovery, Northeastern University, Boston, Massachusetts, United States of America"
        ],
        "Jo\u00e3o D. Seixas": [
            "Instituto de Parasitolog\u00eda y Biomedicina ",
            "Department of Chemistry and Chemical Biology and Center for Drug Discovery, Northeastern University, Boston, Massachusetts, United States of America"
        ],
        "Emanuele Amata": [
            "Department of Chemistry and Chemical Biology and Center for Drug Discovery, Northeastern University, Boston, Massachusetts, United States of America"
        ],
        "William Devine": [
            "Department of Chemistry and Chemical Biology and Center for Drug Discovery, Northeastern University, Boston, Massachusetts, United States of America"
        ],
        "Carlos Cordon-Obras": [
            "Instituto de Parasitolog\u00eda y Biomedicina "
        ],
        "Domingo I. Rojas-Barros": [
            "Instituto de Parasitolog\u00eda y Biomedicina "
        ],
        "Elena Jimenez": [
            "Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain"
        ],
        "Fatima Ortega": [
            "Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain"
        ],
        "Sabrinia Crouch": [
            "Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain"
        ],
        "Gonzalo Colmenarejo": [
            "Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain"
        ],
        "Jose Maria Fiandor": [
            "Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain"
        ],
        "Jose Julio Martin": [
            "Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain"
        ],
        "Manuela Berlanga": [
            "Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain"
        ],
        "Silvia Gonzalez": [
            "Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain"
        ],
        "Pilar Manzano": [
            "Tres Cantos Medicines Development Campus, DDW and CIB, GlaxoSmithKline, Tres Cantos, Spain"
        ],
        "Miguel Navarro": [
            "Instituto de Parasitolog\u00eda y Biomedicina "
        ],
        "Michael P. Pollastri": [
            "Department of Chemistry and Chemical Biology and Center for Drug Discovery, Northeastern University, Boston, Massachusetts, United States of America"
        ]
    }
}